Beranda › Kanker Payudara › Washington › Kennewick
Uji klinis Kanker Payudara di Kennewick, WA
5 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Kennewick (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Menerima pesertaFase 3
- Kadlec Clinic Hematology and Onco, Kennewick
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Kadlec Clinic Hematology and Oncology, Kennewick
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Menerima pesertaFase 3
- Kadlec Clinic Hematology and Oncology, Kennewick
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Kadlec Clinic Hematology and Oncology, Kennewick
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Kadlec Clinic Hematology and Oncology, Kennewick
Uji klinis Kanker Payudara di kota lain
- New York City, NY134 studi
- Houston, TX126 studi
- Boston, MA111 studi
- Nashville, TN80 studi
- Los Angeles, CA72 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Durham, NC63 studi
- Queens, NY63 studi
- Chicago, IL58 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Kennewick
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.